About Epocrates (NASDAQ:EPOC)
Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.
Industry, Sector and Symbol
Industry System Software
Trailing P/E Ratio-39.1
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Epocrates (NASDAQ:EPOC) Frequently Asked Questions
What is Epocrates' stock symbol?
Epocrates trades on the NASDAQ under the ticker symbol "EPOC."
Who are some of Epocrates' key competitors?
Some companies that are related to Epocrates include Covenant Transportation Group (CVTI), SciClone Pharmaceuticals (SCLN), Equity BancShares (EQBK), Agenus (AGEN), Rigel Pharmaceuticals (RIGL), Dicerna Pharmaceuticals (DRNA), Akebia Therapeutics (AKBA), Maiden (MHLD), Heska (HSKA), tronc (TRNC), Natera (NTRA), DXP Enterprises (DXPE), Silicon Image (SIMG), Blue Bird (BLBD), Tactile Systems Technology (TCMD), Five Prime Therapeutics (FPRX), MYR Group (MYRG) and Bandwidth (BAND).
Has Epocrates been receiving favorable news coverage?
Press coverage about EPOC stock has trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Epocrates earned a coverage optimism score of 0.02 on Accern's scale. They also gave media headlines about the company an impact score of 47.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Epocrates?
Shares of EPOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Epocrates' stock price today?
One share of EPOC stock can currently be purchased for approximately $11.73.
How big of a company is Epocrates?
Epocrates has a market capitalization of $291.75 million.
How can I contact Epocrates?
Epocrates' mailing address is 50 Hawthorne, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-4163500.
MarketBeat Community Rating for Epocrates (EPOC)MarketBeat's community ratings are surveys of what our community members think about Epocrates and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Epocrates (NASDAQ:EPOC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Epocrates (NASDAQ:EPOC) Earnings History and Estimates Chart
Epocrates (NASDAQ EPOC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Epocrates (NASDAQ:EPOC) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Epocrates (NASDAQ:EPOC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Epocrates (NASDAQ EPOC)
No insider trades for this company have been tracked by MarketBeat.com
Epocrates (NASDAQ EPOC) News Headlines
Epocrates (NASDAQ:EPOC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Epocrates (NASDAQ:EPOC) Income Statement, Balance Sheet and Cash Flow Statement
Epocrates (NASDAQ EPOC) Stock Chart for Thursday, March, 22, 2018